Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,362 | -3,744 | -1,198 | -10,443 | -10,941 |
| Depreciation Amortization | 2,743 | 1,820 | 893 | 3,478 | 2,600 |
| Income taxes - deferred | N/A | N/A | N/A | 454 | N/A |
| Accounts receivable | 3,942 | 5,305 | 3,036 | -2,160 | 663 |
| Accounts payable and accrued liabilities | -1,906 | -1,211 | -1,154 | 779 | 497 |
| Other Working Capital | -1,090 | 1,413 | 332 | -181 | 1,729 |
| Other Operating Activity | -1,257 | -3,365 | -1,361 | 3,921 | 878 |
| Operating Cash Flow | $-1,930 | $218 | $548 | $-4,152 | $-4,574 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -535 | -217 | -25 | -174 | -150 |
| Investing Cash Flow | $-535 | $-217 | $-25 | $-174 | $-150 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,278 | 4,278 | 2,500 | 42,500 | 0 |
| Debt Repayment | -341 | -231 | -82 | -40,306 | -234 |
| Common Stock Issued | 10 | 10 | N/A | 902 | 34 |
| Other Financing Activity | -19 | -19 | -3 | -2,227 | 0 |
| Financing Cash Flow | $3,928 | $4,038 | $2,415 | $869 | $-200 |
| Exchange Rate Effect | 364 | 29 | -124 | -159 | -217 |
| Beginning Cash Position | 9,459 | 9,459 | 9,459 | 13,075 | 13,075 |
| End Cash Position | 11,286 | 13,527 | 12,273 | 9,459 | 7,934 |
| Net Cash Flow | $1,827 | $4,068 | $2,814 | $-3,616 | $-5,141 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,930 | 218 | 548 | -4,152 | -4,574 |
| Capital Expenditure | -535 | -217 | -25 | -174 | -150 |
| Free Cash Flow | -2,465 | 1 | 523 | -4,326 | -4,724 |